Tectonic Therapeutic, Inc. Common Stock (TECX) is a publicly traded Healthcare sector company. As of August 6, 2026, TECX trades at $30.24 with a market cap of $557.77M and a P/E ratio of -7.34. TECX moved +2.20% today. Year to date, TECX is +44.52%; over the trailing twelve months it is +30.48%. Its 52-week range spans $13.70 to $61.07. Analyst consensus is strong buy with an average price target of $80.75. Rallies surfaces TECX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks politician and congressional stock disclosures for TECX, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
| Metric | Value |
|---|---|
| Price | $30.24 |
| Market Cap | $557.77M |
| P/E Ratio | -7.34 |
| EPS | $-4.05 |
| Dividend Yield | 0.00% |
| 52-Week High | $61.07 |
| 52-Week Low | $13.70 |
| Volume | 56.00K |
| Avg Volume | 0 |
| Revenue (TTM) | $-80.32M |
| Net Income | $-74.15M |
| Gross Margin | 0.00% |
9 analysts cover TECX: 0 strong buy, 9 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $80.75.